Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System-Reference-Cited by-同舟云学术

Effects of Rivastigmine on Cognitive Function in Dementia with Lewy Bodies: A Randomised Placebo-Controlled International Study Using the Cognitive Drug Research Computerised Assessment System

Published:2002 Issue:3 Volume:13 Page:183-192
ISSN:1420-8008
Container-title:Dementia and Geriatric Cognitive Disorders
language:en
Short-container-title:Dement Geriatr Cogn Disord

Author:

Wesnes K.A.,McKeith I.G.,Ferrara R.,Emre M.,Del Ser T.,Spano P.F.,Cicin-Sain A.,Anand R.,Spiegel R.

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Cognitive Neuroscience,Geriatrics and Gerontology

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and correlates of probable rapid eye movement sleep behavior disorder among middle-aged and older adults in a psychiatric outpatient clinic: A cross-sectional survey;Sleep Medicine;2024-09

2. Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies;The Journal of Prevention of Alzheimer's Disease;2024

3. Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial;Iranian Journal of Pharmaceutical Research;2023-10-30

4. Amitriptyline improves cognitive and neuronal function in a rat model that mimics dementia with lewy bodies;Behavioural Brain Research;2022-10

5. Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration;Nature Communications;2022-09-21